« At Behest of NY Delegation, AMA Takes Position on "Code of Conduct" for Health Plans | Main | State Tries to Save Long Island College Maternity Ward »

"New Attitudes, New Opportunities, New York" Welcome news.

November 13, 2008-Governor David A. Paterson announced that New York State has been ranked number one in attracting international investment among all North American destinations – including the United States, Canada and Mexico – according to IBM’s Global Business Services’ recently-released 2007 Global Location Trends Report.

Today’s announcement is welcome news for New York as the economies of our state and nation remain volatile. It is vital that we continue to attract foreign investment, to ensure that New York maintains prominence within the international economy.

According to the Trends Report, New York State received the most international investment in North America as measured by the number of jobs created.
Through Empire State Development (ESD) New York State maintains 14 international offices in key world markets in North America (Toronto, Montreal and Mexico), Latin America (Brazil and Chile), Europe (UK, France and Germany), South Africa, the Middle East (Israel), and Asia (Japan, Hong Kong, Beijing and Shanghai)....provid[ing] market research, guidance and technical assistance to New York State firms seeking new/expanded overseas export market opportunities, and attract international business investment into New York State.
From ESD:
New York State has committed to and realized considerable biomedical industry growth....due, in part, to the significant commitment made by New York State to expand businesses and create new high technology and biotechnology opportunities... [including the Gen*NY*sis Program (Generating Employment through New York State Science), a program focused on all stages of the life sciences research/development process, encouraging collaboration between public and private research institutions with emerging as well as established companies].
The following resources contribute to the State’s extraordinary life sciences infrastructure:
-Center of Excellence in Bioinformatics and Life Sciences at SUNY Buffalo seeks to discover target molecules for use in molecular diagnostics and therapeutic development. (Collaboration:State University of New York at Buffalo, DOH's Roswell Park Cancer Institute, Hauptman Woodward Medical Research Institute,several private life science firms.)
-Center in Biomolecular Diagnostics and Therapeutics at SUNY Stony Brook conducts research/technology development in the areas of functional genomics instrumentation, gene discovery, drug design and delivery, and smart micro- and nano-based biomaterials and biosensors. (Chief partners:Brookhaven National Laboratory and Cold Spring Harbor Laboratory.)
-Center of Disease Modeling and Therapy Discovery at SUNY Buffalo conducts research to develop new therapies to prevent and treat diseases. (Chief partners: Roswell Park Cancer Institute, Hauptman-Woodward Medical Research Institute, Kaleida Health, SUNY Albany, and IBM.)
-The New York Structural Biology Center at City University of New York represents a unique facility that provides New York’s internationally leading researchers with state-of-the-art equipment for research collaboration. (Chief partners: Albert Einstein College of Medicine, Columbia University, Memorial Sloan-Kettering Cancer Center, Mount Sinai School of Medicine, New York University, the Rockefeller University, Wadsworth Center Laboratory, and Weill Medical College of Cornell University.)
-Genomic Technologies & Information Sciences Center at Cornell University focuses on technologies for identifying genes and gene functions. It plans to establish a leading bioinformatics and computational biology research center that applies genomic theories and technologies to solve problems and support State projects in agriculture, biosciences, bioengineering and veterinary medicine.
-Center for Pharmacogenomics at Albany Medical College identifies candidate genes for disease susceptibility, as well as adverse reactions to chemicals and drugs. (Chief partners: Wadsworth Center Laboratory and Health Research, Inc.)
-A research center at Mount Sinai School of Medicine is part of a national and international multidisciplinary consortium that is developing a large-scale project on complex biological systems, with funding from NIH. (Chief partners: SUNY Stony Brook, Cold Spring Harbor Laboratory, and Columbia University.)
For more information, please contact Empire State Development at 1-800-STATE-NY or 1-800 782-8369.
(2) http://www.empire.state.ny.us/High_Tech_Research_and_Development/HighBio_Tech/default.asp

Post a comment

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)


This page contains a single entry from the blog posted on November 17, 2008 9:19 AM.

The previous post in this blog was At Behest of NY Delegation, AMA Takes Position on "Code of Conduct" for Health Plans.

The next post in this blog is State Tries to Save Long Island College Maternity Ward.

Many more can be found on the main index page or by looking through the archives.